Introduction: Management of acute blood loss occasionally requires the expedient release of blood products to maintain hemodynamic stability before complete pretransfusion laboratory testing can be completed. We received clinician complaints over perceived delay in the emergent release of product from the blood bank. Our facility is an independent community hospital, and the laboratory is staffed primarily by generalists. In our investigation we discovered an opportunity for the education of providers at all levels in the existence and application of emergency blood product procedures. Methods: We began tracking the turnaround time (TAT) from request for product to the time of release with a goal of <10 minutes. Our first target for intervention was the laboratory. The blood bank supervisor created a decision tree to aid the generalist in quick and appropriate decision making. Brief didactic sessions were held during shiftchange huddles, and unannounced simulations of emergency situations were held sporadically. Our second target was nursing and clinical staff. Online learning modules centered on bedside processes were created in collaboration with nurse educators and were assigned to all registered nurses. Laboratory technical staff also completed the modules to aid in understanding of interdisciplinary processes. Nursing educators routinely quizzed floor nursing staff. A flowchart detailing emergency release and mass transfusion procedures was created and copies placed in all patient care areas. The medical staff was educated through grand rounds and at medical staff meetings.
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Conclusion:
The incident event had a TAT of 27 minutes. Following the laboratory interventions, the average TAT decreased 68% to 8.5 minutes (n = 9). A further drop of 20% to 6.8 minutes was seen after the nursing interventions (n = 6). We attribute the success to increased understanding of existing procedures and, in particular, interdisciplinary collaboration, which allowed for more efficient communication during stressful situations.
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Hyperhemolysis in a Case of Sickle Cell Anemia
Abhilasha Ghildyal, Luban Alattia, MD, Menchu Ong; Louisiana State University, Shreveport Introduction: Hyperhemolysis is a life-threatening complication of blood transfusion that is usually characterized by a negative direct antiglobulin test (DAT) and reticulocytopenia. Here we present a case of hyperhemolysis in a patient with a positive DAT and reticulocytosis. Clinical Course: A 33-year-old man with a history of sickle cell disease (on hydroxyurea) presented to our institution's emergency department (ED) with complaints of nausea, vomiting, back pain, and blood in the urine. Transfusion history is significant for warm autoantibodies and multiple alloantibodies including anti-C, E, K, Jk A day prior to presentation, he received three units of type B positive, crossmatch-compatible blood. The physical examination was unremarkable. The patient's test results in the ED were as follows: hemoglobin 5.5 g/dL, hematocrit 16.3%, LDH 1766 U/L, total bilirubin 7.5 g/dL, haptoglobin <8 mg/dL, and reticulocyte count 12.2%. The DAT was positive for IgG (2+). The hemoglobin further dropped to 4.9%, and a delayed hemolytic transfusion reaction or hyperhemolysis was suspected. The patient was started on prednisone 1 mg/kg, and all blood transfusions were held. A repeat DAT with IgG was positive (1+). No new antibody was identified. The patient was admitted, and steroid therapy was continued. The patient's hemoglobin level improved to 6.8% on discharge. In the six months since discharge, the patient was doing fine on maintenance steroid therapy with no recent blood transfusions.
Conclusion:
The mechanism of action of hyperhemolysis is not well understood. The DAT is often negative with or without alloantibodies detected. However, it should still be considered in the differential diagnosis of progressive anemia, in a sickle cell disease patient with positive DAT and history of a recent transfusion. Although rare, a high index of suspicion should always be maintained for hyperhemolysis due to its fatal ability. Cold reactive autoantibodies are not usually significant, but on occasion they cause cold hemagglutinin disease (CHD; immune hemolytic anemia). The autoantibodies are usually IgM and efficiently activate complement. They may interfere with ABO typing, Rh(D) typing, the direct antiglobulin test (DAT), antibody detection and identification, and compatibility testing. CHD usually occurs in people over 50 years of age, is most commonly due to anti-i
